ID   Mel Bgf
AC   CVCL_B6KL
SY   mel Bgf
DR   cancercelllines; CVCL_B6KL
DR   Wikidata; Q112129261
RX   CelloPub=CLPUB00680;
RX   Patent=RU2390557;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 714D.
CC   Sequence variation: Mutation; HGNC; 1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (CelloPub=CLPUB00680).
CC   Derived from site: Metastatic; Right thigh, hypodermis; UBERON=UBERON_0000376+UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   57Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 05-10-23; Version: 5
//
RX   CelloPub=CLPUB00680;
RA   Mikhailova I.N., Baryshnikov A.Y., Morozova L.F., Burova O.S.,
RA   Shubina I.Z., Kovalevsky D.A., Voronina E.S., Treshalina H.M.,
RA   Lushnikova A.A., Tsyganova I.V., Mazurenko N.N.;
RT   "Human skin melanoma cell lines collection.";
RL   (In) Management of malignant melanoma; None X. (eds.); pp.6.1-6.6; SM Group; Dover (2016).
//
RX   Patent=RU2390557;
RA   Mikhailova I.N., Baryshnikov A.Y., Demidov L.V., Kiselev S.L.,
RA   Burova O.S., Morozova L.F., Vjacheslavovich S.I.;
RT   "Human melanoma cell line mel Bgf used for making anti-tumour
RT   vaccines.";
RL   Patent number RU2390557, 27-May-2010.
//